Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • January 20, 2024

Tangri N, Rastogi A, Nekeman-Nan C, Hong LS, Ozaki A, Franzén S, Sofue T. Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Jan 19. doi: 10.1007/s12325-023-02773-x. Epub ahead of print. PMID: 38240949.

Tags: Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT2I

Online hemodiafiltration for kidney failure: guidance and best clinical practice recommendations from the Italian Society of Nephrology

Strippoli GFM, Pellegrino G, Hegbrant J, Fabbrini P, Lentini PLM, Aucella F, Panichi V, Gallieni M, Canaud B, Davenport A, Ortiz A, Ramos R, Malyszko[...]

A literature review and reflection on clinical trials: current challenges, future directions, and potential strategies to overcome practical barriers

Zhang K, Lampridis S, Simone CB 2nd, Negoi I, Peng Y, Shang B, Lin Y, Cheng Y, Yang F, Shelat VG, Kalantar-Zadeh K. A literature[...]

Seizure-Induced Rhabdomyolysis Complicated by Acute Kidney Injury: A Case Report

Kaur H, Kennedy HH, Nobakht N. Seizure-Induced Rhabdomyolysis Complicated by Acute Kidney Injury: A Case Report. Am J Case Rep. 2026 Aug 18;27:e951097. doi: 10.12659/AJCR.951097.[...]